Spero Therapeutics, Inc. (SPRO) › Total LiabilitiesSpero Therapeutics, Inc. (SPRO) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2016: $7.41M2017: $8.52M2018: $13.15M2019: $31.53M2020: $21.41M2021: $82.78M2022: $48.87M2023: $75.50M2024: $64.42M2025: $9.90M$9.90M2016Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$9.90M-84.6%2024$64.42M-14.7%2023$75.50M+54.5%2022$48.87M-41.0%2021$82.78M+286.6%2020$21.41M-32.1%2019$31.53M+139.7%2018$13.15M+54.3%2017$8.52M+15.0%2016$7.41M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share